Classification of chronic viral hepatitis: a need for reassessment.
about
Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis CLiver pathology of hepatitis C, beyond grading and staging of the diseaseNon-invasive diagnosis of liver fibrosis in chronic hepatitis CHepatitis C virus: epidemiology and genotypes in the north east of England.Cellular Immune Responses Associated with Occult Hepatitis C Virus Infection of the LiverNon-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis CImmunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathologyUltracentrifugation of Serum Samples Allows Detection of Hepatitis C Virus RNA in Patients with Occult Hepatitis CEarly ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirinSerum Immunoglobulin G Antibodies to the GOR Autoepitope Are Present in Patients with Occult Hepatitis C Virus (HCV) Infection despite Lack of HCV-Specific AntibodiesClonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemiaDifferential Expression of the CXCR3 Ligands in Chronic Hepatitis C Virus (HCV) Infection and Their Modulation by HCV In VitroEvaluation of liver fibrosis: "Something old, something new…"Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 updateHepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic StudyInfluence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patientsDiagnosis, management, and treatment of hepatitis C: an updateIncidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.Factors associated with significant liver necroinflammation in chronic hepatitis B patients with cirrhosisThe Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in ChinaComparison of magnetic resonance elastography and diffusion-weighted imaging for staging hepatic fibrosis.Is liver biopsy still needed in children with chronic viral hepatitis?Non invasive tools for the diagnosis of liver cirrhosis.Invasive and non-invasive diagnosis of cirrhosis and portal hypertensionFactors correlating with acoustic radiation force impulse elastography in chronic hepatitis C.Non-invasive markers for hepatic fibrosisFibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis BImmune response in addicts with chronic hepatitis C treated with interferon and ribavirin.Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C.Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.Hepatitis C virus induces the cannabinoid receptor 1.Differential expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in thioacetamide-induced chronic liver injury.Effects of Haobie Yangyin Ruanjian decoction on hepatic fibrosis induced by carbon tetrachloride in ratsIdentification of groups with poor cost-effectiveness of peginterferon plus ribavirin for naïve hepatitis C patients with a real-world cohort and database.Baseline prediction of combination therapy outcome in hepatitis C virus 1b infected patients by discriminant analysis using viral and host factorsDiversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C
P2860
Q24188065-BB9016BA-28DA-43CC-BBC0-5AAB7A1254B4Q26773294-39263DDD-61B9-48A5-95AE-CBCAC54A6B36Q26865956-21E6D8F3-5C3D-42D4-9C20-BCBF1842A0A8Q27473017-F8828874-1013-40B7-AF73-10D9FB234C74Q27477613-E68468C0-2116-4C2A-B8E2-0CCF23FDFBB2Q27478313-827D078E-0EBA-43CF-882E-7C8F15C189A6Q27478337-5E6955C9-2BC7-4020-827B-6CF09EBC5B64Q27478451-D2D8EE7A-221B-42FD-A72C-C8970958C948Q27480934-A498EED1-716C-4DE3-81AC-7A960D6F9065Q27481147-A32AE711-7806-4D4F-B81D-AE07FC7BE680Q27484587-1026584F-096E-4F4F-B090-F2A8F894661DQ27485227-7D329311-FE51-4AB3-93E8-F16ED58AF894Q27487530-055FB456-9EE1-4B9A-9778-3801D3C03C6FQ28068532-2A151A8D-C6C0-4F2B-9B3E-B930269E9D1DQ28079681-C1220565-EAA2-49E3-B381-8848B568D1CBQ28552246-5AED2E0D-DC1A-4373-B605-6D32EC2C8E77Q28740552-0192B1EA-FA18-4B32-B250-10418549FE68Q29619682-D6ED332C-3BC4-4D03-87D8-616D880B28E9Q30251618-4C948DAA-0FDF-454A-9D80-E94404529F69Q30374334-0C78EF5A-C02F-4368-8E79-125B821BA937Q30383724-FECB6B90-96FD-47FE-B8A8-052FEA9E3EDEQ30384892-47617280-4FD8-4D85-B92B-4E6EA02DED0FQ30398796-6CF4B849-4D59-479D-87E9-7F59BF08EE6BQ30421450-29E6D07A-2BCD-489C-8014-729CD93AA5BDQ30439743-4D3B3F1A-0B1B-4431-A3F1-CE3412A698BEQ30442635-64855E66-C263-4ECF-8EFC-746082D58D5CQ30474093-9BE7B829-1D53-43F6-A55A-6526A6E65715Q31170758-9AF85C45-F2F2-4C3D-9382-F88C947607F2Q33268083-4829C898-33AC-4FF4-A1D5-C5398C9DE73DQ33373813-BA4CBCFD-D01E-4233-BCE4-99DC27B0CD2EQ33422417-E7D77CBB-49F9-4676-B640-107B19743F95Q33423922-AB429171-3502-4D4A-A042-F0D11236CB36Q33586839-C67AB014-954E-402D-A69B-CE68345594A1Q33590508-37B4CEA2-9F8E-4901-AFD2-1CCEADA7E0D5Q33700418-FEE43C47-DC74-45FB-8E58-A1380B70D50EQ33749918-9DC86AD8-E804-4E7E-9FC1-04684C227C5FQ33756248-97AB40C1-2BC9-4CD2-B7EE-DCD1A6846372Q33765497-4B1D3922-248D-44B0-8EB0-17D1B025BC8BQ33770280-289B38D1-7514-4E40-A4A2-0E34EF9106FFQ33779175-6FA9B167-743D-4F76-9045-35727D880E72
P2860
Classification of chronic viral hepatitis: a need for reassessment.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Classification of chronic viral hepatitis: a need for reassessment.
@en
Classification of chronic viral hepatitis: a need for reassessment.
@nl
type
label
Classification of chronic viral hepatitis: a need for reassessment.
@en
Classification of chronic viral hepatitis: a need for reassessment.
@nl
prefLabel
Classification of chronic viral hepatitis: a need for reassessment.
@en
Classification of chronic viral hepatitis: a need for reassessment.
@nl
P1476
Classification of chronic viral hepatitis: a need for reassessment.
@en
P2093
Scheuer PJ
P304
P356
10.1016/0168-8278(91)90084-O
P577
1991-11-01T00:00:00Z